Barclays Maintains Overweight on JBS, Raises Price Target to $23

Benzinga Newsdesk www.benzinga.com Positive 84.4%

Neg 0% Neu 0% Pos 84.4%

Barclays analyst Benjamin Theurer maintains JBS (NYSE:JBS) with a Overweight and raises the price target from $22 to $23.